BenevolentAI claims AI first with new Cambridge facility

| March 8, 2018

article image
The firm says its new facility on the Babraham Research Campus will “radically reduce the time it takes for drug candidates to enter clinical testing”. Ken Mulvany, founder and chairman of BenevolentAI, said: "We have built an artificial intelligence technology that can read and understand the world's biomedical information, then perform complex reasoning, to tell us things about disease never understood before. This enables us to discover new medicines like no other organisation and drive cures for diseases that were previously untreatable.

Spotlight

Hitachi Healthcare Americas

Hitachi Healthcare Americas delivers best in class medical imaging technologies for healthcare providers. Hitachi’s MRI, CT and Ultrasound provide speed, comfort and quality for both physicians and patients and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Our technologies enable unrivalled flexibility in positioning and streamlined workflows for technologists and physicians while allowing patients to be more comfortable resulting in a more cooperative patient and better imaging results. Physicians can grow their business into pediatrics, orthopedics and other unique patient populations while exploring new areas to compete. With an optimized and patient centric approach healthcare providers can deliver strong value into their communities and Hitachi will be there to support them. Our customer first philosophy compels us to make customer support one of the most important things we do. Innovating Healthcare, Embracing th

OTHER ARTICLES

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 4, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 6, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

How pharma can continue engaging HCPs in a world gripped by COVID-19

Article | April 10, 2020

Medscape is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programmes for physicians, nurses, and other healthcare professionals. Both Medscape and Medscape Education are part of WebMD Health Corp., an Internet Brands company. Face-to-face interactions between pharma and physicians have essentially ceased overnight during the COVID-19 pandemic, but that doesn’t mean HCPs have stopped looking for new medical information.

Read More

Spotlight

Hitachi Healthcare Americas

Hitachi Healthcare Americas delivers best in class medical imaging technologies for healthcare providers. Hitachi’s MRI, CT and Ultrasound provide speed, comfort and quality for both physicians and patients and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Our technologies enable unrivalled flexibility in positioning and streamlined workflows for technologists and physicians while allowing patients to be more comfortable resulting in a more cooperative patient and better imaging results. Physicians can grow their business into pediatrics, orthopedics and other unique patient populations while exploring new areas to compete. With an optimized and patient centric approach healthcare providers can deliver strong value into their communities and Hitachi will be there to support them. Our customer first philosophy compels us to make customer support one of the most important things we do. Innovating Healthcare, Embracing th

Events